Omega 3s are on a clear path forward and will continue to trend in the nutraceutical space, according to Christopher Studte, Director New Health Ingredients, Business Line Health Care at Evonik. Studte highlights how Evonik’s omega 3 offering, AvailOm, is suitable for a wide range of solutions, as well as being three to four times more bioavailable than standard soft gel capsules. He also notes that the company is looking into supplying a vegan option, which will hopefully hit the market later this year.
Upcoming webinars

Introducing LifeChews® and the Next Generation of Plant-based Supplements
Sirio

Why ARA & DHA matter: Key lipids shaping infant development
dsm-firmenich

Where Structure Drives Beauty: From Scalp Health to Skin Radiance
Monteloeder















